Connection

David Marshall to Humans

Back to Details
This is a "connection" page, showing publications David Marshall has written about Humans.
David Marshall
Connection Strength
0.213
Humans
  1. Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data. Am J Clin Oncol. 2014 Apr; 37(2):112-6.
    View in: PubMed
    Score: 0.018
  2. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):837-44.
    View in: PubMed
    Score: 0.018
  3. Phase I trial of weekly docetaxel, total androgen blockade, and image-guided intensity-modulated radiotherapy for localized high-risk prostate adenocarcinoma. Clin Genitourin Cancer. 2014 Apr; 12(2):80-6.
    View in: PubMed
    Score: 0.018
  4. Re-irradiation for salvage of prostate cancer failures after primary radiotherapy. World J Urol. 2013 Dec; 31(6):1339-45.
    View in: PubMed
    Score: 0.016
  5. Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab. 2012 Jul; 97(7):2315-24.
    View in: PubMed
    Score: 0.016
  6. Comparison of radiation treatment delivery for pancreatic cancer: Linac intensity-modulated radiotherapy versus helical tomotherapy. J Med Imaging Radiat Oncol. 2012 Jun; 56(3):332-7.
    View in: PubMed
    Score: 0.016
  7. Comparison of intraoperatively built custom linked seeds versus loose seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):1010-6.
    View in: PubMed
    Score: 0.014
  8. Options and recent advances in permanent brachytherapy for prostate cancer. Can J Urol. 2007 Dec; 14 Suppl 1:28-31.
    View in: PubMed
    Score: 0.012
  9. Stage IE primary non-Hodgkin's lymphoma of bone. Clin Orthop Relat Res. 2002 Dec; (405):216-22.
    View in: PubMed
    Score: 0.008
  10. The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation. Int J Radiat Oncol Biol Phys. 2022 05 01; 113(1):66-76.
    View in: PubMed
    Score: 0.008
  11. Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331. J Clin Oncol. 2021 05 10; 39(14):1540-1552.
    View in: PubMed
    Score: 0.007
  12. Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331. J Clin Oncol. 2020 02 20; 38(6):602-612.
    View in: PubMed
    Score: 0.007
  13. S-Glutathionylated Serine Proteinase Inhibitors as Biomarkers for Radiation Exposure in Prostate Cancer Patients. Sci Rep. 2019 09 24; 9(1):13792.
    View in: PubMed
    Score: 0.007
  14. Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017. Clin Cancer Res. 2018 08 01; 24(15):3500-3509.
    View in: PubMed
    Score: 0.006
  15. The impact of metabolic syndrome on outcome and response to neoadjuvant chemoradiation in locally advanced rectal cancer patients. Int J Surg. 2016 Sep; 33 Pt A:8-12.
    View in: PubMed
    Score: 0.005
  16. The impact of surgical diversion before neoadjuvant therapy for rectal cancer. Am Surg. 2015 May; 81(5):444-9.
    View in: PubMed
    Score: 0.005
  17. Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse. J Clin Invest. 2013 Oct; 123(10):4344-58.
    View in: PubMed
    Score: 0.004
  18. Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer. Mol Carcinog. 2014 Feb; 53 Suppl 1:E130-9.
    View in: PubMed
    Score: 0.004
  19. Vitamin D3 supplementation, low-risk prostate cancer, and health disparities. J Steroid Biochem Mol Biol. 2013 Jul; 136:233-7.
    View in: PubMed
    Score: 0.004
  20. Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):481-9.
    View in: PubMed
    Score: 0.003
  21. Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy? J Urol. 2010 Feb; 183(2):634-9.
    View in: PubMed
    Score: 0.003
  22. The multi-disciplinary management of high-risk prostate cancer. Urol Oncol. 2012 Jan-Feb; 30(1):3-15.
    View in: PubMed
    Score: 0.003
  23. High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. J Neurooncol. 2009 Jul; 93(3):343-8.
    View in: PubMed
    Score: 0.003
  24. Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer. Am J Hematol. 2008 Jan; 83(1):87.
    View in: PubMed
    Score: 0.003
  25. Pediatric rhabdomyosarcoma of the head and neck. Curr Treat Options Oncol. 2006 Jan; 7(1):13-22.
    View in: PubMed
    Score: 0.003
  26. Comparison of provincial and territorial legislation governing substitute consent for research. Can J Aging. 2005; 24(3):237-50.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.